Back to Search Start Over

The spectrum of indomethacin-responsive headaches in children and adolescents.

Authors :
Myers, Kenneth A
Barmherzig, Rebecca
Raj, Nichelle R
Berrahmoune, Saoussen
Ingelmo, Pablo
Saint-Martin, Christine
Khan, Afsheen Q
Kouri, Megan
Morris, Cynthia
Hershey, Andrew D
Kacperski, Joanne
Kabbouche, Marielle A
Mohamed, Nada
Rao, Rashmi R
Lagman-Bartolome, Ana Marissa
Gelfand, Amy A
Szperka, Christina L
Orr, Serena L
Source :
Cephalalgia. Jul2022, Vol. 42 Issue 8, p793-797. 5p.
Publication Year :
2022

Abstract

Background: Headaches with marked, specific response to indomethacin occur in children, but the phenotypic spectrum of this phenomenon has not been well-studied. Methods: We reviewed pediatric patients with headache showing ≥80% improvement with indomethacin, from seven academic medical centers. Results: We included 32 pediatric patients (16 females). Mean headache onset age was 10.9 y (range 2–16 y). Headache syndromes included hemicrania continua (n = 13), paroxysmal hemicrania (n = 10), primary stabbing headache (n = 2), short-lasting unilateral neuralgiform headache attacks with conjunctival injection and tearing (n = 1), primary exercise headache (n = 1) and primary cough headache (n = 1). Adverse events were reported in 13, most commonly gastrointestinal symptoms, which often improved with co-administration of gastro-protective agents. Conclusion: Indomethacin-responsive headaches occur in children and adolescents, and include headache syndromes, such as primary cough headache, previously thought to present only in adulthood. The incidence of adverse events is high, and patients must be co-treated with a gastroprotective agent. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
03331024
Volume :
42
Issue :
8
Database :
Academic Search Index
Journal :
Cephalalgia
Publication Type :
Academic Journal
Accession number :
157611922
Full Text :
https://doi.org/10.1177/03331024221076483